AR217411A1 - Procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable - Google Patents

Procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable

Info

Publication number
AR217411A1
AR217411A1 AR265414A AR26541476A AR217411A1 AR 217411 A1 AR217411 A1 AR 217411A1 AR 265414 A AR265414 A AR 265414A AR 26541476 A AR26541476 A AR 26541476A AR 217411 A1 AR217411 A1 AR 217411A1
Authority
AR
Argentina
Prior art keywords
benzoisotiazole
procedure
preparation
pharmaceutically acceptable
addition salt
Prior art date
Application number
AR265414A
Other languages
English (en)
Spanish (es)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Application granted granted Critical
Publication of AR217411A1 publication Critical patent/AR217411A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AR265414A 1975-11-18 1976-11-10 Procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable AR217411A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4737375 1975-11-18

Publications (1)

Publication Number Publication Date
AR217411A1 true AR217411A1 (es) 1980-03-31

Family

ID=10444739

Family Applications (3)

Application Number Title Priority Date Filing Date
AR265414A AR217411A1 (es) 1975-11-18 1976-11-10 Procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable
AR269611A AR215271A1 (es) 1975-11-18 1977-10-17 Un procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable
AR269610A AR217449A1 (es) 1975-11-18 1977-10-17 Procedimiento para la preparacion de derivados de 1,2-benzoisotiozol 3-ona y una sal de adicion acida farmaceuticamente aceptable

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR269611A AR215271A1 (es) 1975-11-18 1977-10-17 Un procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable
AR269610A AR217449A1 (es) 1975-11-18 1977-10-17 Procedimiento para la preparacion de derivados de 1,2-benzoisotiozol 3-ona y una sal de adicion acida farmaceuticamente aceptable

Country Status (28)

Country Link
US (5) US4113728A (xx)
JP (1) JPS5262273A (xx)
AR (3) AR217411A1 (xx)
AT (1) AT355017B (xx)
AU (2) AU504599B2 (xx)
BE (1) BE848371A (xx)
BG (4) BG24808A3 (xx)
CA (1) CA1064511A (xx)
CH (1) CH627465A5 (xx)
CS (4) CS192592B2 (xx)
DD (1) DD127645A5 (xx)
DE (1) DE2652201A1 (xx)
DK (1) DK517776A (xx)
ES (3) ES453420A1 (xx)
FI (1) FI763285A (xx)
FR (1) FR2332019A1 (xx)
HU (1) HU173958B (xx)
IL (1) IL50690A (xx)
NL (1) NL7612796A (xx)
NO (1) NO763922L (xx)
NZ (1) NZ182325A (xx)
PH (1) PH13918A (xx)
PL (1) PL193742A1 (xx)
PT (1) PT65851B (xx)
RO (4) RO75540A (xx)
SE (1) SE7612919L (xx)
SU (4) SU682129A3 (xx)
ZA (1) ZA766489B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
US4190663A (en) * 1976-01-24 1980-02-26 Bayer Aktiengesellschaft Anti-thrombotic 1,2-benzisothiazolin-3-ones
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
DE2860750D1 (en) * 1977-06-20 1981-09-17 Beecham Group Plc Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
EP0001503B1 (en) * 1977-10-08 1981-01-07 Beecham Group Plc Antithrombotic compositions containing benzisothiazolones
EP0026791B1 (en) * 1979-10-08 1984-05-02 Merck & Co. Inc. 2-aryl-1,2-benzisothiazolinone-1,1-dioxides and pharmaceutical compositions containing them
DE3226284A1 (de) * 1982-07-14 1984-01-19 A. Nattermann & Cie GmbH, 5000 Köln Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3238006A1 (de) * 1982-10-13 1984-04-19 Bayer Ag, 5090 Leverkusen Azolyl-methylamine, ihre herstellung und verwendung in mikrobiziden mitteln
DE3500577A1 (de) * 1985-01-10 1986-07-10 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 1,2-benzisothiazolonen
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
CA1340759C (en) * 1988-07-01 1999-09-21 James P. Albarella Isobenzothiazolone chromogenic thiol indicators and their derivatives
US5128457A (en) * 1988-07-01 1992-07-07 Miles Inc. Chromogenic thiol indicators based on an isobenzothiazolone ring system
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
EP2344479B1 (en) * 2008-09-23 2015-04-08 Georgetown University 1,2-benzisothiazolinone and isoindolinone derivatives
WO2013025897A1 (en) 2011-08-16 2013-02-21 Georgetown University Methods of treating bacterial infections with 1,2-benzisothiazolinone and isoindolinone derivatives
US20180318818A1 (en) 2015-10-19 2018-11-08 Emory University Redox Dehydration Coupling Catalysts and Methods Related Thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE565380A (xx) * 1957-03-08
US3012039A (en) * 1958-03-14 1961-12-05 Ici Ltd 2-p-chlorobenzyl-1, 2-benzisothiazolone
DE1147947B (de) * 1961-07-25 1963-05-02 Knoll Ag Verfahren zur Herstellung neuer 1, 2-Benzisothiazolone
SE392103B (sv) * 1970-04-27 1977-03-14 Sherwin Williams Co Sett att framstella 1,2-bensisotiazolin-3-oner
US3661974A (en) * 1970-04-27 1972-05-09 Sherwin Williams Co 2-carbalkoxy-phenyl sulfenamides
NZ182325A (en) * 1975-11-18 1979-03-16 Beecham Group Ltd 2-substituted-1,2-benzisothiazol-3-ones
GB1582214A (en) * 1977-05-31 1981-01-07 Beecham Group Ltd Antithrombotic compositions
DE2734882A1 (de) * 1977-08-03 1979-02-22 Basf Ag 3- eckige klammer auf 4-(1,3-diazacycloalken-2-yl)-phenyl eckige klammer zu -1,2-benzisothiazole, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
PT65851B (en) 1978-05-15
CS192592B2 (en) 1979-08-31
FI763285A (xx) 1977-05-19
NZ182325A (en) 1979-03-16
AU4716379A (en) 1979-09-27
FR2332019B1 (xx) 1983-05-20
AT355017B (de) 1980-02-11
AR215271A1 (es) 1979-09-28
IL50690A (en) 1980-01-31
US4212872A (en) 1980-07-15
AU504599B2 (en) 1979-10-18
RO75777A (ro) 1981-02-28
PH13918A (en) 1980-11-04
ES453420A1 (es) 1978-02-16
FR2332019A1 (fr) 1977-06-17
CS192570B2 (en) 1979-08-31
ES465174A1 (es) 1978-10-01
IL50690A0 (en) 1976-12-31
US4350702A (en) 1982-09-21
PT65851A (en) 1976-12-01
AR217449A1 (es) 1980-03-31
CS192594B2 (en) 1979-08-31
US4243669A (en) 1981-01-06
SU679141A3 (ru) 1979-08-05
ES465173A1 (es) 1978-10-01
AU1916376A (en) 1978-05-04
HU173958B (hu) 1979-09-28
RO75730A (ro) 1981-02-28
SU682129A3 (ru) 1979-08-25
ATA849176A (de) 1979-07-15
AU520890B2 (en) 1982-03-04
BG24808A3 (en) 1978-05-12
US4113728A (en) 1978-09-12
BG24809A3 (en) 1978-05-12
SU701536A3 (ru) 1979-11-30
BE848371A (fr) 1977-05-16
US4212979A (en) 1980-07-15
JPS5262273A (en) 1977-05-23
DE2652201A1 (de) 1977-06-02
CS192593B2 (en) 1979-08-31
DD127645A5 (xx) 1977-10-05
BG24810A3 (en) 1978-05-12
BG24811A3 (en) 1978-05-12
SE7612919L (sv) 1977-05-19
DK517776A (da) 1977-05-19
CA1064511A (en) 1979-10-16
ZA766489B (en) 1977-10-26
NL7612796A (nl) 1977-05-23
SU671728A3 (ru) 1979-06-30
CH627465A5 (de) 1982-01-15
PL193742A1 (pl) 1979-05-21
NO763922L (xx) 1977-05-20
RO69608A (ro) 1982-07-06
RO75540A (ro) 1980-11-30

Similar Documents

Publication Publication Date Title
AR217411A1 (es) Procedimiento para la preparacion de derivados de 1,2-benzoisotiazol-3-ona y una sal de adicion acida farmaceuticamente aceptable
MX3591E (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
AR222624A1 (es) Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada
MX4236E (es) Procedimiento para la preparacion de acidos alcanoicos de heteroarilbenzoxepina
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
AR212858A1 (es) Procedimiento para la preparacion de derivados farmaceuticamente activos fenipolieno carboxilicos
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR207727A1 (es) Procedimiento y dispositivo para la preparacion de una mezcla particularmente una mezcla fraguable para la construccion
MX5702E (es) Procedimiento para la preparacion de una mezcla de esteroisomeros de alfa-ciano-3-fenoxibencil-2-(4-clorofenil)isovalerato
AR217240A1 (es) Procedimiento para preparar derivados acilamino sustituidos de 1,2,4-oxadiazol,1,3-4-oxadiazol,1,2,4-tiadiazol y 1,3,4-tiadiazol,terapeuticamente utiles
MX5599E (es) Procedimiento para la preparacion de una composicion farmaceutica a base de trihidrato de amoxicilina
AR222443A1 (es) Un procedimiento para la preparacion de una penicilina,o una sal,farmaceuticamente aceptable de la misma
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
AR210888A1 (es) Procedimiento para la preparacion de nuevas benzamidas 2,4-disustituidas,2,5-disustituidas y 2,4,5-trisustituidas
AR199720A1 (es) Procedimiento para la preparacion de derivados de 3-formilrifamicina "sv"
MX4640E (es) Procedimiento mejorado para la preparacion de derivados de xanteno
MX5632E (es) Procedimiento mejorado para la preparacion de levo n-(1-etil-2-pirrolidinometil)-2-metoxi-5-sulfamoilbenzamida
IT1075534B (it) Acidi 5-fenilcarbammoil-barbiturici,procedimento per la loro preparazione e loro impiego per combattere insetti
AR215869A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-fenil-2-aminoetanol
AR212174A1 (es) Procedimiento para la preparacion de derivados de las 1-aminometil-6,7-dihidroxi-1,2,3,4-tetrahidroisoquinoleinas
MX3903E (es) Procedimiento para la preparacion de derivados de 1,4-benzodiazepina 2-sustitudos
AR209152A1 (es) Procedimiento para la preparacion de una fraccion soluble de proteinas de soja
MX3519E (es) Procedimiento para la preparacion de n-(1-etil-2-pirrolidilmetil)-2-metoxi-5-sulfamoil benzamida